Lonza News 4 févr. 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News 4 févr. 2026 Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail
Lonza News 30 janv. 2026 CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine
Lonza News 29 janv. 2026 Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
Lonza News 29 janv. 2026 Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
Lonza News 29 janv. 2026 Switzerland’s Lonza edges closer to sale of its capsule and health ingredients business - 93.3 The Drive
Endpoints News 28 janv. 2026 Lonza still intends to sell its capsules and health ingredients business
Lonza News 28 janv. 2026 Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Lonza News 28 janv. 2026 Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
Lonza News 28 janv. 2026 Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
Lonza News 28 janv. 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - Reuters
Lonza News 28 janv. 2026 Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com